[Septicemia due to Leptotrichia buccalis in an immuno-suppressed patent (author's transl)]. 1982

J L Kohler, and D Raoult, and H Gallais, and M Pons, and Y Peloux, and P Casanova

The authors report a case of septicemia due to Leptotrichia buccalis in a patient with underlying lymphatic leukemia. It is the second case reported in the literature. This observation shows, once again, that bacteria known as "non virulent" can exhibit pathogenicity in immunosuppressed patients.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D006089 Gram-Negative Anaerobic Bacteria A large group of anaerobic bacteria which show up as pink (negative) when treated by the Gram-staining method. Gram Negative Anaerobic Bacteria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014747 Vinblastine Antitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.) Vincaleukoblastine,Cellblastin,Lemblastine,Velban,Velbe,Vinblastin Hexal,Vinblastina Lilly,Vinblastine Sulfate,Vinblastinsulfat-Gry,Sulfate, Vinblastine
D014751 Vindesine Vinblastine derivative with antineoplastic activity against CANCER. Major side effects are myelosuppression and neurotoxicity. Vindesine is used extensively in chemotherapy protocols (ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS). Compound 112531,Desacetylvinblastine Amide,Eldisine,Enison,NSC-245467,Vindesin,Vindesine Sulfate,NSC 245467,NSC245467,Sulfate, Vindesine

Related Publications

J L Kohler, and D Raoult, and H Gallais, and M Pons, and Y Peloux, and P Casanova
June 1968, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
J L Kohler, and D Raoult, and H Gallais, and M Pons, and Y Peloux, and P Casanova
February 1984, Canadian Medical Association journal,
J L Kohler, and D Raoult, and H Gallais, and M Pons, and Y Peloux, and P Casanova
January 1965, Archives of oral biology,
J L Kohler, and D Raoult, and H Gallais, and M Pons, and Y Peloux, and P Casanova
August 1985, Journal of clinical microbiology,
J L Kohler, and D Raoult, and H Gallais, and M Pons, and Y Peloux, and P Casanova
October 1996, Liver,
J L Kohler, and D Raoult, and H Gallais, and M Pons, and Y Peloux, and P Casanova
January 1980, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
J L Kohler, and D Raoult, and H Gallais, and M Pons, and Y Peloux, and P Casanova
October 1979, Haematologica,
J L Kohler, and D Raoult, and H Gallais, and M Pons, and Y Peloux, and P Casanova
January 1981, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
J L Kohler, and D Raoult, and H Gallais, and M Pons, and Y Peloux, and P Casanova
January 1976, Archives of oral biology,
J L Kohler, and D Raoult, and H Gallais, and M Pons, and Y Peloux, and P Casanova
June 1982, Revue medicale de Bruxelles,
Copied contents to your clipboard!